- Report
- September 2025
- 476 Pages
Global
From €5130EUR$5,850USD£4,480GBP
- Report
- September 2025
- 386 Pages
Global
From €5130EUR$5,850USD£4,480GBP
- Report
- September 2025
- 386 Pages
Global
From €5130EUR$5,850USD£4,480GBP
- Report
- September 2025
- 489 Pages
Global
From €5130EUR$5,850USD£4,480GBP
- Report
- September 2025
- 361 Pages
Global
From €5130EUR$5,850USD£4,480GBP
- Report
- September 2025
- 265 Pages
Global
From €5130EUR$5,850USD£4,480GBP
- Report
- September 2025
- 452 Pages
Global
From €5130EUR$5,850USD£4,480GBP
- Report
- September 2025
- 480 Pages
Global
From €5130EUR$5,850USD£4,480GBP
- Report
- September 2025
- 279 Pages
Global
From €5130EUR$5,850USD£4,480GBP
- Report
- September 2025
- 294 Pages
Global
From €5130EUR$5,850USD£4,480GBP
- Report
- September 2025
- 290 Pages
Global
From €5130EUR$5,850USD£4,480GBP
- Report
- September 2025
- 464 Pages
Global
From €5130EUR$5,850USD£4,480GBP
- Report
- September 2025
- 281 Pages
Global
From €5130EUR$5,850USD£4,480GBP
- Report
- September 2025
- 364 Pages
Global
From €5130EUR$5,850USD£4,480GBP
- Report
- September 2025
- 377 Pages
Global
From €5130EUR$5,850USD£4,480GBP
- Report
- September 2025
- 476 Pages
Global
From €5130EUR$5,850USD£4,480GBP
- Report
- September 2025
- 288 Pages
Global
From €5130EUR$5,850USD£4,480GBP
- Report
- September 2025
- 483 Pages
Global
From €5130EUR$5,850USD£4,480GBP
- Report
- September 2025
- 138 Pages
Global
From €5130EUR$5,850USD£4,480GBP
- Report
- September 2025
- 207 Pages
Global
From €5130EUR$5,850USD£4,480GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more